Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas (Q48455787)

11 February 2018

title

Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas (English)

1 reference

11 February 2018

1 reference

4

1 reference

11 February 2018

author name string

Kazuya Motomura

1

1 reference

11 February 2018

Atsushi Natsume

2

1 reference

11 February 2018

Reiko Watanabe

3

1 reference

11 February 2018

Yukinari Kato

5

1 reference

11 February 2018

Hiroyuki Momota

6

1 reference

11 February 2018

Ryo Nishikawa

7

1 reference

11 February 2018

Kazuhiko Mishima

8

1 reference

11 February 2018

Yoko Nakasu

9

1 reference

11 February 2018

Tatsuya Abe

10

1 reference

11 February 2018

Hiroki Namba

11

1 reference

11 February 2018

Yoichi Nakazato

12

1 reference

11 February 2018

Hiroshi Tashiro

13

1 reference

11 February 2018

Ichiro Takeuchi

14

1 reference

11 February 2018

Tsutomu Mori

15

1 reference

11 February 2018

Toshihiko Wakabayashi

16

1 reference

11 February 2018

publication date

7 August 2012

1 reference

11 February 2018

published in

Cancer Science

1 reference

11 February 2018

volume

103

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

1871-1879

1 reference

11 February 2018

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

cites work

1 reference

12 December 2020

O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma

1 reference

12 December 2020

Podoplanin associates with CD44 to promote directional cell migration

1 reference

12 December 2020

The 2007 WHO classification of tumours of the central nervous system

1 reference

12 December 2020

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations

1 reference

12 December 2020

A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report

1 reference

12 December 2020

Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells

1 reference

12 December 2020

The oligodendrocyte precursor cell in health and disease

1 reference

12 December 2020

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

12 December 2020

IDH1 and IDH2 mutations in gliomas

1 reference

12 December 2020

Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.

1 reference

12 December 2020

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression

1 reference

12 December 2020

Medulloblastoma comprises four distinct molecular variants

1 reference

12 December 2020

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

12 December 2020

CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma

1 reference

12 December 2020

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

12 December 2020

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

1 reference

12 December 2020

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

12 December 2020

The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma

1 reference

12 December 2020

An integrated genomic analysis of human glioblastoma multiforme

1 reference

12 December 2020

A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs

1 reference

12 December 2020

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

1 reference

12 December 2020

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

1 reference

12 December 2020

A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study).

1 reference

12 December 2020

Benefits of interferon‐β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter

1 reference

12 December 2020

Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding

1 reference

12 December 2020

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

1 reference

12 December 2020

Gene dosage and mutational analyses of EGFR in oligodendrogliomas

1 reference

12 December 2020

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

1 reference

12 December 2020

Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma

1 reference

12 December 2020

Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors

1 reference

12 December 2020

Efficient serum-free derivation of oligodendrocyte precursors from neural stem cell-enriched cultures

1 reference

12 December 2020

Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain

1 reference

12 December 2020

Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain

1 reference

12 December 2020

Transcriptional control of oligodendrogenesis

1 reference

12 December 2020

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

12 December 2020

Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02377.X

Identifiers

DOI

1 reference

11 February 2018

release_4rbzjg4aq5bxdcitm6zskiisyy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4rbzjg4aq5bxdcitm6zskiisyy

24 November 2022

mapped directly with Wikidata item

1 reference

11 February 2018